Therapeutic Advances in Chronic Disease (May 2022)

COVID-19-induced psoriatic arthritis: a case report

  • Francis Essien,
  • Lisa Chastant,
  • Collen McNulty,
  • Matthew Hubbard,
  • Luria Lynette,
  • Matthew Carroll

DOI
https://doi.org/10.1177/20406223221099333
Journal volume & issue
Vol. 13

Abstract

Read online

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which may lead to uncontrolled immune activation and cytokine response in some. The pattern of pro-inflammatory cytokines is similar to that which has been observed to be involved in rheumatic diseases and target treatments. Viral arthritis is common with a wide variety in spectrum ranging from arthralgia to spurious and chronic arthritis. However, recent studies have demonstrated a correlation with endemic coronaviruses and increased risk of developing rheumatoid arthritis (RA). Cases are being identified that describe a post-COVID reactive; however, to date, no report has been published describing the onset of psoriasis and concomitant development of psoriatic arthritis after COVID-19 infection. We report an interesting case of psoriatic arthritis in a post-COVID-19 infection patient with review of the current literature.